Abstract
The Epstein-Barr virus (EBV)-encoded latent membrane protein 1 (LMP1) has a significant role in initiating EBV-associated lymphoproliferative disease and EBV-related malignancies. In view of clinical features related to the type of EBV latency, LMP1 may influence invasiveness of EBV associated tumors categorized as types II and III as represented on nasopharyngeal carcinoma (NPC). To screen for genes associated with invasion of epithelial cells transformed by LMP1, Madin-Darby canine kidney (MDCK) epithelial cells were transformed by LMP1. Stable transfection of a LMP1 gene into MDCK cells induced morphological change from cobblestone to a long spindle-shape, reduced cell-cell adhesion and caused high cell motility. Parental MDCK cells, which form spherical cysts in three-dimensional collagen gel matrix, form branching tubules following exposure to hepatocyte growth factor (HGF). MDCK cells transformed by LMP1 showed invasive growth to form branching tubules into collagen gel without HGF-treatment. mRNA differential display and Northern hybridization identified plasminogen activator inhibitor-1 (PAI-1), urokinase type plasminogen activator (uPA) and ets1 as genes upregulated during transformation by LMP1. Expression of a dominant negative type of Ets1 in LMP1-transformed cells downregulated uPA expression and cell motility. Deletion of LMP1 cytoplasmic carboxy-terminal activating region 1 (CTAR1) domain abolished transformation, but a deletion mutant lacking CTAR2 domain still retained transforming and uPA-inducing ability. Expression of Ets1 was immunolocalized in tumor cells of NPC tissue which frequently express LMP1. Taken together, it is suggested that LMP1 induces expression of Ets1 which may contribute to invasion of NPC by stimulating cell motility and uPA expression.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Baichwal VR and Sugden B . 1988 Oncogene 2: 461–467
Bardelli A, Maina F, Gout I, Fry MJ, Waterfield MD, Comoglio PM and Ponzetto C . 1992 Oncogene 7: 1973–1978
Bindal AK, Hammoud M, Shi WM, Wu SZ, Sawaya R and Rao JS . 1994 J Neurooncol 22: 101–110
D'Orazio D, Besser D, Marksitzer R, Kunz C, Hume DA, Kiefer B and Nagamine Y . 1997 Gene 201: 179–187
Davies G, Jiang WG and Mason MD . 1999 Anticancer Res 19: 547–552
Dawson CW, Rickinson AB and Young LS . 1990 Nature 344: 777–780
Delannoy CA, Mattot V, Fafeur V, Fauquette W, Pollet I, Calmels T, Vercamer C, Boilly B, Vandenbunder B and Desbiens X . 1998 J Cell Sci 111: 1521–1534
Devergne O, Hatzivassiliou E, Izumi KM, Kaye KM, Kleijnen MF, Kieff E and Mosialos G . 1996 Mol Cell Biol 16: 7098–7108
Dittmer J and Nordheim A . 1998 Biochimica et Biophysica Acta 1377: 1–11
Eliopoulos AG and Young LS . 1998 Oncogene 16: 1731–1742
Fafeur V, Tulasne D, Queva C, Vercamer C, Dimster V, Mattot V, Stehelin D, Desbiens X and Vandenbunder B . 1997 Cell Growth Differ 8: 655–665
Fahraeus R, Rymo L, Rhim JS and Klein G . 1990 Nature 345: 447–449
Foekens JA, Schmitt M, van Putten WLJ, Peters HA, Kramer MO, Janicke F and Klijin JGM . 1994 J Clin Oncol 12: 1648–1658
Fries KL, Miller WE and Raab TN . 1996 J Virol 70: 8653–8659
Gilles F, Raes MB, Stehelin D, Vandenbunder B and Fafeur V . 1996 Exp Gcll Res 222: 370–378
Grisendi S, Arpin M and Crepaldi T . 1998 J Cell Physiol 176: 465–471
Grondaho-Hansen J, Christensen IJ, Rosenquist C, Brunner N, Mouridsen HT, Dano K and Blichert-Toft M . 1993 Cancer Res 53: 2513–2521
Henderson S, Rowe M, Gregory C, Croom CD, Wang F, Longnecker R, Kieff E and Rickinson A . 1991 Cell 65: 1107–1115
Hiscox S and Jiang WG . 1999 Anticancer Res 19: 509–517
Huen DS, Henderson SA, Croom CD and Rowe M . 1995 Oncogene 10: 549–560
Izumi KM, Kaye KM and Kieff ED . 1997 Proc Natl Acad Sci USA 94: 1447–1452
Kadono Y, Okada Y, Namiki M, Seiki M and Sato H . 1998a Cancer Res 58: 2240–2244
Kadono Y, Shibahara K, Namiki M, Watanabe Y, Seiki M and Sato H . 1998b Biochem Biophys Res Commun 251: 681–687
Kaye KM, Devergne O, Harada JN, Izumi KM, Yalamanchili R, Kieff E and Mosialos G . 1996 Proc Natl Acad Sci USA 93: 11085–11090
Kaye KM, Izumi KM, Mosialos G and Kieff E . 1995 J Virol 69: 675–683
Kieff E . 1996 Virology, Fields BN, Knipe DM and Howley PM eds. 3rd edn Lippinscott-Raven Publishers Philadelphia, PA pp 2343–2396
Kola I, Brookes S, Green AR, Garber R, Tymms M, Papa TS and Seth A . 1993 Proc Natl Acad Sci USA 90: 7588–7592
Liebowitz D and Kieff Y . 1993 The human herpesviruses Roizman B, Whitley RJ and Lopez C eds. Raven Press Ltd NY pp 107–172
Liotta LA . 1992 Sci Am 266: 54–59
Miller G . 1990 Virology, Fields BN and Knipe DM eds. 2nd Ed Lippinscott-Raven Publishers Philadelphia, PA pp 1921–1958
Miller WE, Earp HS and Raab TN . 1995 J Virol 69: 4390–4398
Miller WE, Mosialos G, Kieff E and Raab TN . 1997 J Virol 71: 586–594
Montesano R, Schaller G and Orci L . 1991a Cell 66: 697–711
Montesano R, Matsumoto K, Nakamura T and Orci L . 1991b Cell 67: 901–908
Mosialos G, Birkenbach M, Yalamanchili R, VanArsdale T, Ware C and Kieff E . 1995 Cell 80: 389–399
Nabeshima K, Shimao Y, Inoue T, Itoh H, Kataoka H and Koono M . 1998 Int J Cancer 78: 750–759
Nakada M, Yamashita J, Okada Y and Sato H . 1999 J Neuropathol Exp Neurol 58: 329–334
Nakayama T, Ito M, Ohtsuru A, Naito S, Nakashima M, Fagin JA, Yamashita S and Sekine I . 1996 Am J Pathol 149: 1931–1939
Noritake H, Miyamori H, Goto C, Seiki M and Sato H . 1999 Clinic Exp Met 17: 105–110
Pelicci G, Giordano S, Zhen Z, Salcini AE, Lanfrancone L, Bardelli A, Panayotou G, Waterfield MD, Ponzetto C, Pelicci PG et al. 1995 Oncogene 10: 1631–1638
Ponzetto C, Bardelli A, Zhen Z, Maina F, dalla ZP, Giordano S, Graziani A, Panayotou G and Comoglio PM . 1994 Cell 77: 261–271
Queva C, Leprince D, Stehelin D and Vandenbunder B . 1993 Oncogene 8: 2511–2520
Rickinson A and Kieff E . 1996 Virology, Fields BN, Knipe DM and Howley PM eds. 3rd Edn Lippinscott-Raven Publishers Philadelphia, PA pp 2397–2446
Sappino AP, Belin D, Huarte J, Hirschel SS, Saurat JH and Vassalli JD . 1991 J Clin Invest 88: 1073–1079
Sato H, Kida Y, Mai M, Endo Y, Sasaki T, Tanaka J and Seiki M . 1992 Oncogene 7: 77–83
Stacey KJ, Fowles LF, Colman MS, Ostrowski MC and Hume DA . 1995 Mol Cell Biol 15: 3430–3441
Takeshita H, Yoshizaki T, Miller W, Sato H, Furukawa M, Pagano JS and Raab-Traub N . 1999 J Virol 73: 5548–5555
Testa JE and Quigley JP . 1990 Cancer Metastasis Rev 9: 353–367
Vandenbunder B, Pardanaud L, Jaffredo T, Mirabel MA and Stehelin D . 1989 Development 107: 265–274
Wang F, Gregory C, Sample C, Rowe M, Liebowitz D, Murray R, Rickinson A and Kieff E . 1990 J Virol 64: 2309–2318
Watabe T, Yoshida K, Shindoh M, Kaya M, Fujikawa K, Sato H, Seiki M, Ishii S and Fujinaga K . 1998 Int J Cancer 77: 128–137
Yoshizaki T, Sato H, Furukawa M and Pagano JS . 1998 Proc Natl Acad Sci USA 95: 3621–3626
Young LS, Dawson CW, Clark D, Rupani H, Busson P, Tursz T, Johnson A and Rickinson AB . 1988 J GenVirol 69: 1051–1065
Young LS and Rowe M . 1992 Semin Cancer Biol 3: 273–284
Acknowledgements
We thank Dr EW Thompson for critical reading of the manuscript, Dr N Raab-Traub for expression plasmids for truncated LMP1, and Dr LA Young for the monoclonal antibody against LMP1. This work was supported by a Grant-in-Aid for Scientific Research on Priority Areas from the Ministry of Education, Science, and Culture of Japan and by a grant from NOVARTIS Foundation (Japan) for the Promotion of Science.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kim, KR., Yoshizaki, T., Miyamori, H. et al. Transformation of Madin-Darby canine kidney (MDCK) epithelial cells by Epstein-Barr virus latent membrane protein 1 (LMP1) induces expression of Ets1 and invasive growth. Oncogene 19, 1764–1771 (2000). https://doi.org/10.1038/sj.onc.1203502
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1203502